R. Mark Evans, PhD. Director, Healthcare Education Products and Standards

R. Mark Evans, PhD
Director, Healthcare Education Products and Standards

You need a Flash Player to listen introduction audion.

Click here to download latest version.





Medical Forum
primarycare.org

Current Opinions in Depression Management

Current Opinions in Depression Management

Left to right:
Wayne Katon, MD
Jeffrey Susman, MD

Module 1: Gaps in Accuracy of Diagnosis and Quality of Treatment

Module 2: Overlap of Depression with Physical Symptoms and Medical Disorders

Module 3: Interpreting STAR*D

Module 4: Collaborative Care and Comorbidity Models

Introduction

One of the most significant changes in the approach to the management of depression in the primary care setting has been the application of the chronic disease model to this condition, and to approach depression as a relapsing, remitting condition analogous to other chronic conditions such asthma. Because of the link between residual symptoms of depression and relapse, the physician needs to treat depression to remission and then to monitor the patient's longer term response utilizing a measurement tool like the PHQ-9. Dr. Wayne Katon, University of Washington School of Medicine and Dr. Jeffrey Susman, University of Cincinnati School of Medicine will discuss the current state of diagnosis and management of depression from both the psychiatric and family physician perspective and explore the challenge for the primary care physician in making the diagnosis of depression in the setting of other conditions such as diabetes, hypertension, chronic headache, GI distress and other pain symptoms and implementing evidenced-based approaches to treatment.

Intended Audience

This continuing medical education program is intended for primary care physicians and other healthcare professionals who manage patients with major depressive disorder.

Educational Objectives

After completing this activity, participants should be better able to:

  • Recognize important areas for quality improvement in the diagnosis and management of depression.
  • Improve the accuracy of depression diagnosis in the presence of somatic symptoms, such as pain and comorbid disorders.
  • Apply the findings of STAR*D to better manage depression in the primary care setting.
  • Identify options for appropriate and effective therapeutic strategies to achieve remission in patients with persistent depression.
  • Describe how a collaborative care model and chronic care model may improve the quality of care and outcomes in depressed patients including those with comorbid disease.

Information on CME credit

The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The American Medical Association designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Nonphysicians may receive a certificate of participation for completing this activity.

Instructions for CME credit

This online enduring material is presented as a video webcast with attendant slide presentation. To receive credit, please view all of the presentations of this CME activity and evaluate the content presented. Complete both the pre- and post-test and activity evaluation.

The estimated time to complete this activity, including pre-test, review of the materials, and self-assessment and evaluation is 1.0 hour.

Advisory Board

Wayne Katon, MD
Professor and Vice Chair
Department of Psychiatry and Behavioral Sciences
Director, Division of Health Services and Psychiatric Epidemiology
University of Washington School of Medicine
Seattle, WA

Michael S. Klinkman, MD
Associate Professor, Department of Medicine
Associate Professor, Department of Psychiatry
Department of Family Medicine
Director, Primary Care Programs
University of Michigan Depression Center
Ann Arbor, MI

Kurt Kroenke, MD
Professor of Medicine
Indiana University School of Medicine
Research Scientist, Regenstrief Institute, Inc.
Indianapolis, IN

John Williams, MD
Associate Professor of Medicine and Psychiatry
General Medicine
Duke University School of Medicine
Durham, NC

Editorial Board

R. Mark Evans, PhD
Director, Healthcare Education Products and Standards
American Medical Association
Chicago, IL

Kristi Eidsvoog, PhD
Content Manager
MedEd Architects, LLC
Chicago, IL

Patti Fitzgerald
Manager, Product Development, Healthcare Education Products and Standards
American Medical Association
Chicago, IL

Faculty

Wayne Katon, MD
Professor and Vice Chair
Department of Psychiatry and Behavioral Sciences
Director, Division of Health Services and Psychiatric Epidemiology
University of Washington School of Medicine
Seattle, WA

Jeffrey Susman, MD
Professor and Chair
Department of Family Medicine
University of Cincinnati College of Medicine
Cincinnati, OH

Disclosure Policy

In order to assure the highest quality of CME programming, and to comply with the ACCME Standards for Commercial Support, the AMA requires that all faculty and planning committee members disclose relevant financial relationships with any commercial or proprietary entity producing health care goods or services relevant to the content being presented. We therefore obtain a completed disclosure and attestation form to inform the participant of any pertinent relationships disclosed, provided here.

These materials have been peer-reviewed by the members of the Program Advisory Board and the AMA Editorial Board to ensure the continued scientific accuracy and medical relevance of information presented and its independence from commercial bias. The AMA has control over all final content.

Dr. Katon: Advisory Board, Lilly, Wyeth; Speakers Bureau, Pfizer, Forest, GlaxoSmithKline

Dr. Klinkman: Advisory Board, Wyeth; Research Grant, Lilly; Independent Contractor, GE/Healthology

Dr. Kroenke: Research Grant, Lilly, Pfizer, Wyeth; Consultant, Lilly, Pfizer, Wyeth

Dr. Susman: Advisory Board, Pfizer, Forest, Wyeth; Consultant, Pfizer, Forest, Wyeth; Speaker's Bureau, Pfizer, Forest , Wyeth

Dr. Williams: Nothing relevant to disclose

Dr. Evans: Nothing relevant to disclose

Dr. Eidsvoog: Nothing relevant to disclose

Ms. Fitzgerald: Nothing relevant to disclose

Acknowledgement of Support

These CME offerings are supported through an independent education grant from Eli Lilly and Company, and produced in accordance with the AMA Standards for Industry-Supported Multimedia Continuing Medical Education and Other Communications.

Term of approval

Original Release Date- September 2007

Date of the Most Recent Review- December 2009

Expiration Date- December 2010


System Requirements


Disclaimer